Minnesota SF 1054: Metropolitan Council advisory committee and Metropolitan Parks and Open Space Commission member compensation authorization

Status: Referred to Transportation (as of 2023-02-01)

State: Minnesota · Session: 2023-2024 · Bill: SF 1054

Subjects: Councils, Metropolitan Area, Parks and Trails

Sponsors: Dibble

Bill Text

1.1 A bill for an act​
1.2 relating to health insurance; requiring coverage of vasectomies by health plans;​
1.3 requiring the medical assistance program and MinnesotaCare to cover vasectomies;​
1.4 amending Minnesota Statutes 2024, sections 62Q.522, subdivision 1; 256B.0625,​
1.5 by adding a subdivision.​
1.6 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
1.7 Section 1. Minnesota Statutes 2024, section 62Q.522, subdivision 1, is amended to read:​
1.8 Subdivision 1.Definitions.(a) The definitions in this subdivision apply to this section.​
1.9 (b) "Contraceptive method" means a drug, device, or other product approved by the​
1.10 Food and Drug Administration to prevent unintended pregnancy.​
1.11 (c) "Contraceptive service" means consultation, examination, procedures, and medical​
1.12 services related to the prevention of unintended pregnancy, excluding vasectomies. This​
1.13 includes but is not limited to voluntary sterilization procedures, patient education, counseling​
1.14 on contraceptives, and follow-up services related to contraceptive methods or services,​
1.15 management of side effects, counseling for continued adherence, and device insertion or​
1.16 removal.​
1.17 (d) "Medical necessity" includes but is not limited to considerations such as severity of​
1.18 side effects, difference in permanence and reversibility of a contraceptive method or service,​
1.19 and ability to adhere to the appropriate use of the contraceptive method or service, as​
1.20 determined by the attending provider.​
1.21 (e) "Therapeutic equivalent version" means a drug, device, or product that can be expected​
1.22 to have the same clinical effect and safety profile when administered to a patient under the​
1.23 conditions specified in the labeling, and that:​
1​Section 1.​
S1054-1 1st Engrossment​SF1054 REVISOR RSI​
SENATE​
STATE OF MINNESOTA​
S.F. No. 1054​NINETY-FOURTH SESSION​
(SENATE AUTHORS: MANN, Abeler, Maye Quade, Wiklund and Hemmingsen-Jaeger)​
OFFICIAL STATUS​D-PG​DATE​
Introduction and first reading​302​02/06/2025​
Referred to Commerce and Consumer Protection​
Author stricken Lieske​626​03/03/2025​
Comm report: To pass as amended and re-refer to Health and Human Services​692a​03/10/2025​
Author added Hemmingsen-Jaeger​6992​03/25/2026​

2.1 (1) is approved as safe and effective;​
2.2 (2) is a pharmaceutical equivalent: (i) containing identical amounts of the same active​
2.3 drug ingredient in the same dosage form and route of administration; and (ii) meeting​
2.4 compendial or other applicable standards of strength, quality, purity, and identity;​
2.5 (3) is bioequivalent in that:​
2.6 (i) the drug, device, or product does not present a known or potential bioequivalence​
2.7 problem and meets an acceptable in vitro standard; or​
2.8 (ii) if the drug, device, or product does present a known or potential bioequivalence​
2.9 problem, it is shown to meet an appropriate bioequivalence standard;​
2.10 (4) is adequately labeled; and​
2.11 (5) is manufactured in compliance with current manufacturing practice regulations.​
2.12 EFFECTIVE DATE.This section is effective January 1, 2026, and applies to health​
2.13 plans offered, issued, or renewed on or after that date.​
2.14 Sec. 2. Minnesota Statutes 2024, section 256B.0625, is amended by adding a subdivision​
2.15 to read:​
2.16 Subd. 77.Vasectomies.(a) Medical assistance covers vasectomies.​
2.17 (b) Medical assistance must meet the requirements with respect to coverage of​
2.18 vasectomies that would otherwise apply to a health plan under section 62Q.522, except that​
2.19 medical assistance is not required to comply with any provision of section 62Q.522 if​
2.20 compliance with the provision would:​
2.21 (1) prevent the state from receiving federal financial participation for the coverage under​
2.22 this subdivision;​
2.23 (2) result in a lower level of coverage or reduced access to coverage for medical assistance​
2.24 enrollees; or​
2.25 (3) violate Code of Federal Regulations, title 42, part 441, subpart F.​
2.26 EFFECTIVE DATE.This section is effective January 1, 2026, or upon federal approval,​
2.27 whichever is later. The commissioner of human services shall notify the revisor of statutes​
2.28 when federal approval is obtained.​
2​Sec. 2.​
S1054-1 1st Engrossment​SF1054 REVISOR RSI​

View Minnesota SF 1054 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.